MedPath

TEGRETOL SUSPENSION

TEGRETOL SUSPENSION

Approved
DIN Number

02194333

Drug Class

Human

Market Date

Dec 31, 1996

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02194333
AIG Number0108674002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AF01 CARBAMAZEPINE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARBAMAZEPINEActive
Strength: 100 MG / 5 ML
Monograph: CARBAMAZEPINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.